Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
Director departure
VIA Pharmaceuticals, Inc. (VIAP) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/25/2011 15-12G Form 15-12G - Securities registration termination [Section 12(g)]
03/24/2011 10-K Annual Report for the period ended December 31, 2010
02/11/2011 SC 13G Cohen Lawrence Kenneth reports a 5.5% stake in VIA Pharmaceuticals, Inc.
01/18/2011 8-K Quarterly results
01/03/2011 EFFECT Form EFFECT - Notice of Effectiveness
01/03/2011 EFFECT Form EFFECT - Notice of Effectiveness
01/03/2011 EFFECT Form EFFECT - Notice of Effectiveness
01/03/2011 EFFECT Form EFFECT - Notice of Effectiveness
01/03/2011 EFFECT Form EFFECT - Notice of Effectiveness
01/03/2011 EFFECT Form EFFECT - Notice of Effectiveness
01/03/2011 EFFECT Form EFFECT - Notice of Effectiveness
12/30/2010 POS AM Form POS AM - Post-Effective amendments for registration statement
12/30/2010 POS AM Form POS AM - Post-Effective amendments for registration statement
12/30/2010 POS AM Form POS AM - Post-Effective amendments for registration statement
12/30/2010 POS AM Form POS AM - Post-Effective amendments for registration statement
12/30/2010 POS AM Form POS AM - Post-Effective amendments for registration statement
12/30/2010 POS AM Form POS AM - Post-Effective amendments for registration statement
12/30/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/30/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/30/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/30/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/30/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/30/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/30/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
12/30/2010 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
11/22/2010 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
11/17/2010 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/17/2010 D/A Form D - Notice of Exempt Offering of Securities [amend]
11/17/2010 4 GIVEN DOUGLAS B (Director) has filed a Form 4 on VIA Pharmaceuticals, Inc.
Txns: Bought 12,065 warrants @ $0.071, valued at $856.6
11/17/2010 4 CRAVES FRED B (Director) has filed a Form 4 on VIA Pharmaceuticals, Inc.
Txns: Bought 3,671,806 warrants @ $0.071, valued at $260.7k
Bought 60,495 warrants @ $0.071, valued at $4.3k
11/16/2010 4 BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on VIA Pharmaceuticals, Inc.
Txns: Bought 41,361,972 warrants @ $0.071, valued at $2.9M
Bought 891,549 warrants @ $0.071, valued at $63.3k
Bought 8,272,394 warrants @ $0.071, valued at $587.3k
Bought 149,927 warrants @ $0.071, valued at $10.6k
Bought 1,654,479 warrants @ $0.071, valued at $117.5k
Bought 29,985 warrants @ $0.071, valued at $2.1k
11/15/2010 10-Q Quarterly Report for the period ended September 30, 2010
11/04/2010 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Promissory Note, by VIA Pharmaceuticals, Inc. and payable to Bay City Capital Fund IV, L.P"
09/29/2010 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy